Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
Riess C, Schneider B, Kehnscherper H, Gesche J, Irmscher N, Shokraie F, Classen CF, Wirthgen E, Domanska G, Zimpfer A, Strüder D, Junghanss C, Maletzki C.
Riess C, et al. Among authors: classen cf.
Front Immunol. 2020 Feb 14;11:55. doi: 10.3389/fimmu.2020.00055. eCollection 2020.
Front Immunol. 2020.
PMID: 32117235
Free PMC article.